23andMe Investor Day Presentation Deck

Limited Use of Genetic Data and Lack of Patient Engagement Constrain Productivity 1. IND= Investigational New Drug Application. fdareview.org, "The Drug Development and Approval Process" (2020). 2. Probability of success for a drug to be approved is estimated to be <12%. 3. PhRMA, "Biopharmaceutical Research & Development: The Process Behind New Medicines" (2015). Drug Development is Inefficient 7 years average time-to-IND¹ $2.6B average cost of drug development³ ~90% failure rate2, 3 Copyright © 2022 23andMe, Inc. 23andMe® 11

View entire presentation